Carlo Putzu

Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab

Carlo Putzu, Diego Cortinovis, Francesca Colonese et al. · Cancer Immunology Immunotherapy · 2018 · 75 citations · Full text

Oncology, Cancer Management, Bronchial Neoplasm +4

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

Francesco Perrone, Michelino De Laurentiis, Sabino De Placido et al. · European Journal of Cancer · 2019 · 68 citations

Ovarian Function Suppression, Oncology, Breast Oncology +13

Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate

Heikki Joensuu, Filippo de Braud, Paola Coco et al. · Annals of Oncology · 2007 · 62 citations · Full text

Phase Ii, Gastrointestinal Oncology, Medicine +5

Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study

Grazia Palomba, Valentina Doneddu, Antonio Cossu et al. · Journal of Translational Medicine · 2016 · 55 citations · Full text

Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations

Antonio Passaro, Arsela Prelaj, Laura Bonanno et al. · Clinical Lung Cancer · 2018 · 55 citations

Medicine, Genetic Epidemiology, Caucasian Patients +7